BioCentury
ARTICLE | Clinical News

ATI-9242: Phase I started

April 28, 2008 7:00 AM UTC

ARYx began a double-blind, placebo-controlled Phase I (CLN-901) trial of oral ATI-9242 in healthy volunteers. ...